Squarepoint Ops LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 168 filers reported holding PTC THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$302,535
-87.8%
13,500
-79.2%
0.00%
-90.0%
Q4 2022$2,479,790
-64.6%
64,967
-53.4%
0.01%
-71.4%
Q3 2022$6,999,000
+94.5%
139,423
+55.2%
0.04%
+75.0%
Q2 2022$3,599,000
+105.0%
89,839
+90.9%
0.02%
+150.0%
Q1 2022$1,756,000
+491.2%
47,056
+650.4%
0.01%
+300.0%
Q1 2021$297,000
-53.4%
6,271
-54.0%
0.00%
-77.8%
Q3 2020$638,000
+127.0%
13,638
+146.7%
0.01%
+80.0%
Q2 2020$281,000
-36.1%
5,529
-43.9%
0.01%
-54.5%
Q1 2020$440,000
-56.1%
9,855
-66.7%
0.01%
+22.2%
Q3 2019$1,002,000
-34.6%
29,613
-27.2%
0.01%
-43.8%
Q1 2019$1,531,000
+5.5%
40,685
-3.8%
0.02%
-5.9%
Q4 2018$1,451,000
+5.8%
42,287
+44.8%
0.02%
+6.2%
Q3 2018$1,372,000
-3.5%
29,200
-30.7%
0.02%
-15.8%
Q2 2018$1,422,000
+77.1%
42,157
+42.1%
0.02%
+46.2%
Q1 2018$803,000
+64.2%
29,677
+1.2%
0.01%
+44.4%
Q4 2017$489,000
+26.7%
29,337
+39.4%
0.01%
+12.5%
Q2 2017$386,000
-15.0%
21,049
-49.5%
0.01%
-57.9%
Q4 2016$454,000
+22.4%
41,643
+57.3%
0.02%
-24.0%
Q3 2016$371,000
+13.5%
26,478
-47.9%
0.02%0.0%
Q1 2016$327,000
+42.2%
50,800
+615.5%
0.02%0.0%
Q4 2015$230,000
-38.0%
7,100
-48.9%
0.02%
-73.1%
Q3 2015$371,000
-39.1%
13,900
+39.0%
0.09%
-56.3%
Q1 2015$609,00010,0000.21%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders